Evolus (NASDAQ: EOLS) reported Q3 EPS of ($0.30), $0.18 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $61.1 million versus the consensus estimate of $63.18 million.

GUIDANCE:

Evolus sees FY2024 revenue of $260-266 million, versus the consensus of $266.6 million.

Evolus sees FY2028 revenue of ~$700 million, versus the consensus of $688.5 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.